Samuel A. Wickline is the Chief Scientific Officer of Altamira Therapeutics.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
![]() |
Chief Scientific Officer | Jun 1, 2021 | — | Detail |